to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness: adults and children 12 years and over • take 1 to 2 chewable tablets every 4-6 hours • do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor children 6 to under 12 years • give 1/2 to 1 chewable tablet every 6-8 hours • do not give more than 3 chewable...
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
• nausea • vomiting • dizziness
for children under 2 years of age unless directed by a doctor
• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• trouble urinating due to an enlarged prostate gland
you are taking sedatives or tranquilizers
• marked drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery
ask a doctor before use.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
to prevent or treat motion sickness:
| adults and children 12 years and over | • take 1 to 2 chewable tablets every 4-6 hours • do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor |
| children 6 to under 12 years | • give 1/2 to 1 chewable tablet every 6-8 hours • do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor |
| children 2 to under 6 years | • give 1/2 chewable tablet every 6-8 hours • do not give more than 1-1/2 chewable tablets in 24 hours, or as directed by a doctor |
•
Phenylketonurics: contains phenylalanine 0.84 mg per tablet
• store at room temperature 20º-25ºC (68º- 77ºF)
• do not use if pouch is opened
• see pouch for lot number and expiration date
anhydrous citric acid, aspartame, FD&C yellow 6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol
call 1-800-382-7219
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67751-170-01 | 2025-01-30 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| 67751-170-02 | 2025-01-30 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| 67751-170-01 | 2023-03-15 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| 67751-170-02 | 2023-03-15 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| 67751-170-01 | 2023-01-30 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| 67751-170-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-155a-0266-e053-dadaa90a7c1a | Dramamine |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-170-01 | Dramamine | 1 in 1 CARTON | TABLET | 1 | 3 | |
| 67751-170-01 | Dramamine | 2 in 1 POUCH | TABLET | 2 | 3 | |
| 67751-170-02 | Dramamine | 1 in 1 CARTON | TABLET | 1 | 3 | |
| 67751-170-02 | Dramamine | 4 in 1 POUCH | TABLET | 4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67751-170 | 67751-170-01, 67751-170-02 |
| 63029-901 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SORBITOL | 506T60A25R | IACT |
| DIMENHYDRINATE | JB937PER5C | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dramamine Original Formula | DIMENHYDRINATE | Medtech Products Inc. | f9302a5a-295a-4501-9332-e3f5eb387362 | 2025-10-23 | Warnings | 63029-901 |
| f6f79a87-6831-c39d-e053-6394a90ae629 | 4139b5bf-2e49-40c3-9f4a-d8e15c044ead | 2023-03-15 | Warnings | f6f79a87-6831-c39d-e053-6394a90ae629 4139b5bf-2e49-40c3-9f4a-d8e15c044ead |
Adverse event summaries are temporarily unavailable. Other product information remains available.